Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016-Reference-Cited by-同舟云学术

Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016

Published:2020-11-09 Issue:12 Volume:23 Page:1558-1569
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

MacEwan Joanna P.¹,Dennen Syvart¹,Kee Rebecca¹^ORCID,Ali Farzad²,Shafrin Jason¹,Batt Katharine³

Affiliation:

1. PRECISIONheor, Los Angeles, CA, USA

2. Pfizer Inc, New York, NY, USA

3. Independent Hematologist, Raleigh-Durham, NC, USA

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1834403

Reference84 articles.

1. American Cancer Society. Global Cancer Facts & Figures 4th Edition. 2018 March 2, 2020. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures/global-cancer-facts-and-figures-4th-edition.pdf

2. American Cancer Society. Cancer facts & figures 2018. 2018.

3. American Cancer Society. Economic impact of cancer. 2018 [accessed 2020 Mar 2]. Available from: https://www.cancer.org/cancer/cancer-basics/economic-impact-of-cancer.html

4. National and State Estimates of Lost Earnings From Cancer Deaths in the United States

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy;Discover Oncology;2024-08-11

2. Orthotopic and metastatic tumour models in preclinical cancer research;Pharmacology & Therapeutics;2024-05

3. Global Pipeline of Innovative Medicinal Products: A Narrative Review;Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2024-02-27

4. Clinical benefit of anti-PD-(L)1 immunotherapies in advanced cancer in France: a population-based estimate from 2014 to 2021;ESMO Open;2024-02

5. The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations;Future Oncology;2024-01-23